Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05343182 · ClinicalTrials.gov registry record · NA
Vestibulectomy Surgical Techniques Comparison Study
A NA study of Vulvodynia and Vulvar Pain, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- NA
- Development phase
- 118
- Enrollment target
- 1
- Study location
NCT05343182: Recruiting NA study of Vulvodynia and Vulvar Pain, sponsored by Oregon Health and Science University.
NCT05343182 is a NA study of Vulvodynia and Vulvar Pain that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 118 participants, roughly in line with the 125-participant average among 9 other Vulvodynia trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05343182, a NA study of Vulvodynia and Vulvar Pain, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- NA
- Development phase
- 118 participants
- Enrollment target
- 1
- Study location
Study Summary
Vestibulectomy Surgical Techniques Comparison Study
Primary Outcome
The change from baseline in pain measured by the Tampon Test at 3 months after surgery. The tampon test is a validated tool used to measure (vulva) vestibular skin pain by having participants insert and remove a tampon. Participants will be asked to rate their pain along a 100 mm Visual Analog Scale on a scale of 0 (No pain) to 10 (Pain as bad as you can imagine). This test will occur at baseline and 3 months follow up.
Conditions Studied
Interventions
- OTHER Modified Technique
- OTHER Traditional Technique
Study Locations (1)
Oregon
- Oregon Health and Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2022-10-06 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT05343182 shows while recruiting
NCT05343182 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 125-participant average among 9 other Vulvodynia trials with a reported enrollment target.
The record links to 2 conditions, with Vulvodynia appearing as the primary indexed condition, and to 2 interventions - of which Modified Technique is the first listed.
NCT05343182 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT05343182 about?
NCT05343182 is a clinical study titled "Vestibulectomy Surgical Techniques Comparison Study". Vestibulectomy Surgical Techniques Comparison Study
What is the current status of trial NCT05343182?
This trial is currently recruiting. It is a NA study. The enrollment target is 118 participants. The study started on 2022-10-06. Estimated completion is 2027-06.
What conditions does trial NCT05343182 study?
This clinical trial studies the following conditions: Vulvodynia, Vulvar Pain.
What interventions are being tested in trial NCT05343182?
The interventions under investigation include: Modified Technique (OTHER), Traditional Technique (OTHER).
Who is sponsoring clinical trial NCT05343182?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05343182 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vulvodynia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05343182's enrollment target sits among peer trials
118 4th of 9 higher than 6 of 9 other Vulvodynia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vulvodynia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Acupuncture for Vulvodynia: A Pre-pilot Study
COMPLETED · NA
-
Acupuncture for the Treatment of Vulvodynia
COMPLETED · NA
-
A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response
COMPLETED · NA
-
Topical Ketotifen 0.25% for Secondary Vestibulodynia
RECRUITING · Phase 2
-
Prospective Data Bank Creation to Study Vaginal Conditions
RECRUITING
-
Validation of Patient Reported Outcome Measures for Use in Vulvodynia
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI